BMO: IAMGOLD’s Review Of Cote Operations Expected To Be Negative

On April 18, BMO Capital Markets lowered their 12-month price target and downgraded IAMGOLD Corporation (TSX: IMG). BMO now has a $2.75 12-month price target, down from $4.00, and has a market perform rating, which was lowered from outperform. BMO says that this downgrade comes after doing a review of their estimates as well as a review “on valuation as IAMGOLD share prices have appreciated YTD,” given the equity is up 19% year to date.

IAMGOLD currently has 10 analysts covering the stock with an average 12-month price target of C$4.10. Out of the 10 analysts, 2 have buy ratings, 7 have hold ratings and 1 analyst has a sell rating on the stock. The highest 12-month price target comes in at C$6.50, which represents a 39% upside to the current stock price.

First, BMO believes that the Côté review is negative. IAMGOLD currently is reviewing the project scope and budget, which is expected to be released in the second quarter of this year. They believe that the results will be negative versus IAMGOLD’s guidance. BMO says that they are estimating the project to spend US$1.96 billion, slightly above the company’s US$1.866 billion estimates. They add, “we see risk that the budget could grow further.”

Additionally, BMO has slashed their estimates for full-year 2022 and 2023, though they expect IAMGOLD to see a strong first-quarter result due to strong results at Essakane and Rosebel/Saramacca. They admit that their previous estimates were significantly above 2022 guidance and have revised down accordingly.

Lastly, BMO believes that the agreement between Resource Capital Funds, which prompted a whole new selection of Board of Directors and an expected announcement of a new “strong permanent CEO,” will be a positive catalyst for the stock in the coming months. They do believe a weak readthrough of Côté would outweigh those positives.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Mercado Minerals Identifies A Series Of New Targets Following LiDAR Survey At Copalito

Related News

Netflix: Canaccord Increases Subscriber Growth Estimates

Last week, Netflix (NASDAQ: NFLX) announced that Universal and Netflix have extended their exclusive license...

Friday, July 23, 2021, 04:43:00 PM

Else Nutrition: Canaccord Drops Price Target To $5.75

On Friday, Else Nutrition (CSE: BABY) reported their fourth quarter and year end financials. The...

Monday, May 3, 2021, 11:44:00 AM

Activision Sees BMO Lower Estimates After Disappointing Quarter

Recently Activision Blizzard (NASDAQ: ATVI) reported its first quarter financial results. The company reported revenues...

Saturday, May 7, 2022, 05:11:00 PM

Cresco Labs: Canaccord, Eight Capital Raise Price Targets

Cresco Labs (CSE: CL) reported its second-quarter 2020 financials yesterday, posting revenue growth of 42%...

Friday, August 21, 2020, 04:03:00 PM

IAMGOLD Q3 2025: Revenue Jumps 61%, Earnings Fall On Impairment

IAMGOLD (TSX: IMG) reported a 61% year over year jump on revenue to $706.7 million...

Wednesday, November 5, 2025, 10:22:16 AM